Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6407914 | 0.92 | RAB9A (0.48) | LMNAMAPK14POLBSMN1; SMN2MDM2 | |
| SCHEMBL6405248 | 0.91 | POLB (0.57) | LMNAMAPK14POLBSMN1; SMN2MDM2 | |
| SCHEMBL6405537 | 0.90 | NPC1 (0.54) | LMNAPOLBSMN1; SMN2MDM2RAB9A | |
| SCHEMBL6407567 | 0.90 | KMT2A (0.55) | LMNAPOLBSMN1; SMN2MDM2RAB9A | |
| SCHEMBL6403186 | 0.85 | KMT2A (0.53) | LMNAPOLBSMN1; SMN2MDM2RAB9A | |
| SCHEMBL6405096 | 0.84 | NPC1 (0.50) | LMNAPOLBSMN1; SMN2RAB9ANPC1 | |
| SCHEMBL6407948 | 0.83 | BCHE (0.45) | LMNAPOLBSMN1; SMN2MDM2RAB9A | |
| SCHEMBL6403880 | 0.83 | TDP1 (0.51) | LMNAMAPK14POLBSMN1; SMN2RAB9A | |
| SCHEMBL6405981 | 0.83 | NPC1 (0.57) | LMNASMN1; SMN2RAB9ANPC1MEN1 | |
| SCHEMBL6410547 | 0.82 | NPC1 (0.55) | LMNAMAPK14POLBSMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050171358-A1 | Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide | SDS BIOTECH K.K. (JP) | 2005-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171358-A1 | Substituted isoxazole alkylamine derivative and agri-and horticultural fungicide | AHR, ERG28, CYP1A2 | LMNA 3019/4885MAPK14 2923/4885POLB 3713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.